Closed
SectorHealthcare
3.34 2.77
24h
Min
3.25
Max
3.51
Income | -16M 3M |
---|---|
Sales | -13M 46M |
P/E Sector Avg | 4.903 56.602 |
EPS | 0.1 |
Profit margin | 6.464 |
Employees | 172 |
EBITDA | -14M 4M |
Recommendations | Neutral |
---|---|
12 Months Forecast | +49.31% upside |
Next Earnings | 31 lip 2025 |
---|
Market Cap | -8.4M 151M |
---|---|
Previous open | 0.57 |
Previous close | 3.34 |
By Acuity
60%
40%
325 / 382 Ranking in Healthcare
By Trading Central
Confidence
Weak Bullish Evidence
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
Price change
By TipRanks
12 Months Forecast
Average 4.33 USD 49.31%
High 7 USD
Low 2 USD
Based on 3 Wall Street analysts offering 12 month price targets forPuma Biotechnology Inc - Dist in the last 3 months.
By Acuity
News Sentiment
Bearish Evidence
Volatility
Below average
News Volume (RCV)
Below average
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$